Results
15
Popular and high growth companies which might be overvalued.
15 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
WTC | AU$92.02 | -1.5% | 7.4% | AU$31.5b | AU$92.15 | PE137.9x | E24.0% | 0.2% | Software | ||
REA | AU$195.60 | -0.7% | 23.5% | AU$26.0b | AU$190.03 | PE91.7x | E27.8% | 0.9% | Media | ||
PDN | AU$11.34 | -11.8% | 50.2% | AU$3.5b | AU$16.08 | PE39.9x | E39.1% | n/a | Energy | ||
LTR | AU$0.92 | -7.6% | -67.2% | AU$2.3b | AU$1.14 | PB2.8x | E49.3% | n/a | Materials | ||
CMM | AU$5.25 | -3.5% | 8.9% | AU$2.1b | AU$5.68 | PE106.6x | E32.0% | n/a | Materials | ||
SIG | AU$1.30 | -2.6% | 66.7% | AU$2.0b | AU$1.14 | PE452.8x | E42.5% | 0.8% | Healthcare | ||
LFS | AU$1.15 | -1.7% | -3.4% | AU$1.2b | n/a | PS2.9x | E138.4% | 0% | Diversified Financials | ||
CUV | AU$14.98 | -1.7% | -19.9% | AU$756.2m | AU$30.33 | PE24.9x | E26.8% | 0.3% | Pharmaceuticals & Biotech | ||
ANG | AU$0.62 | 0% | 129.6% | AU$351.9m | n/a | PE17.4x | E27.3% | 1.3% | Capital Goods | ||
ARX | AU$0.63 | 5.0% | -34.4% | AU$216.9m | n/a | PS3.5x | E99.2% | n/a | Pharmaceuticals & Biotech | ||
A1M | AU$0.33 | -9.6% | -15.4% | AU$188.4m | n/a | PE116.9x | E48.5% | n/a | Materials | ||
CYC | AU$1.55 | -9.4% | -29.2% | AU$172.3m | AU$3.08 | PS6.3x | E94.9% | 0% | Healthcare | ||
NOL | AU$1.41 | 0.4% | -15.9% | AU$119.2m | AU$2.83 | PE44.1x | E36.1% | n/a | Insurance | ||
AVA | AU$0.13 | 0% | -33.3% | AU$37.3m | n/a | PS1.3x | E91.5% | n/a | Tech | ||
MGL | AU$0.32 | -8.6% | -35.4% | AU$27.1m | n/a | PE54.7x | E66.7% | 3.8% | Materials |